Active ingredient
Cisatracurium
41 finished FDA listings contain Cisatracurium as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- CISATRACURIUM BESYLATE
- Dosage forms
- Injection, Injection, Solution
- Routes
- Intravenous
- Manufacturers / labelers
- 15
- Strengths listed
- 10 mg/5ml · 10 mg/ml · 2 mg/ml · 20 mg/10ml · 200 mg/20ml
- Brand names in FDA listings
- Cisatracurium
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 319864
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| ANDA 200154 | SANDOZ INC | 2012-02-03 | 2 |
| ANDA 200159 | SANDOZ INC | 2012-02-03 | 1 |
| ANDA 203182 | FRESENIUS KABI USA | 2015-02-26 | 2 |
| ANDA 203183 | FRESENIUS KABI USA | 2015-02-26 | 1 |
| ANDA 203238 | HOSPIRA | 2018-03-30 | 1 |
| ANDA 203236 | HOSPIRA | 2018-03-30 | 2 |
| ANDA 206791 | SOMERSET THERAPS LLC | 2019-02-20 | 2 |
| ANDA 209132 | SOMERSET | 2019-04-24 | 1 |
| ANDA 211669 | MEITHEAL | 2019-04-25 | 2 |
| ANDA 211668 | MEITHEAL | 2019-04-25 | 4 |
| ANDA 212171 | ZYDUS PHARMS | 2019-11-04 | 4 |
| ANDA 209144 | EUGIA PHARMA | 2020-05-08 | 1 |
| ANDA 209665 | EUGIA PHARMA | 2020-10-27 | 1 |
| ANDA 212432 | PIRAMAL | 2022-03-11 | 3 |
| ANDA 215516 | GLAND | 2022-05-24 | 3 |
| ANDA 203078 | HIKMA | 2022-06-28 | 2 |
| ANDA 203079 | HIKMA | 2023-04-19 | 1 |
| ANDA 217725 | CAPLIN | 2023-06-09 | 4 |
| ANDA 216538 | HAINAN POLY | 2024-03-08 | 1 |
| ANDA 216539 | HAINAN POLY | 2024-08-27 | 3 |
Official labeling on DailyMed
- CISATRACURIUM BESYLATE INJECTION, SOLUTION [AVENACY, LLC] · version 1 · 2026-08-17
- CISATRACURIUM BESYLATE INJECTION, SOLUTION [HOSPIRA, INC.] · version 15 · 2026-05-28
- CISATRACURIUM BESYLATE INJECTION [SOMERSET THERAPEUTICS, LLC] · version 10 · 2026-05-13
- CISATRACURIUM BESYLATE INJECTION [SOMERSET THERAPEUTICS, LLC] · version 10 · 2026-05-13
- CISATRACURIUM BESYLATE INJECTION [CAMBER PHARMACEUTICALS INC.] · version 2 · 2026-05-05
- CISATRACURIUM BESYLATE INJECTION [EUGIA US LLC] · version 6 · 2025-11-27
- CISATRACURIUM BESYLATE INJECTION [HIKMA PHARMACEUTICALS USA INC.] · version 5 · 2025-05-16
- CISATRACURIUM BESYLATE INJECTION [HIKMA PHARMACEUTICALS USA INC.] · version 4 · 2025-05-16
- CISATRACURIUM BESYLATE INJECTION [GLAND PHARMA LIMITED] · version 4 · 2025-04-11
- CISATRACURIUM (CISATRACURIUM BESYLATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] · version 9 · 2025-03-24
- CISATRACURIUM BESYLATE INJECTION [SANDOZ INC] · version 12 · 2025-03-21
- CISATRACURIUM BESYLATE INJECTION [ARMAS PHARMACEUTICALS] · version 1 · 2025-03-03
Showing the 12 most recent of 20 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.